IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 1, 2014, Pages 367-372

  Hams, Emily ^a,b   Armstrong, Michelle E ^a,b   Barlow, Jillian L ^c   Saunders, Sean P ^a,b   Schwartz, Christian ^d   Cooke, Gordon ^e   Fahy, Ruairi J ^f   Crotty, Thomas B ^g   Hirani, Nikhil ^h   Flynn, Robin J ^c   Voehringer, David ^d   McKenzie, Andrew N J ^c   Donnelly, Seamas C ^e,g   Fallon, Padraic G ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^c MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e UNIVERSITY COLLEGE DUBLIN   (Ireland)

^f ST JAMES S HOSPITAL   (Ireland)

^g ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cytokine; Inflammation; Innate response; Therapy

Indexed keywords

COLLAGEN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 25; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INNATE IMMUNITY; LUNG FIBROSIS; LUNG LAVAGE; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TYPE 2 INNATE LYMPHOID CELL;

CYTOKINE; INFLAMMATION; INNATE RESPONSE; THERAPY;

AGED; ANIMALS; CELL ADHESION MOLECULES; COLLAGEN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-13; INTERLEUKIN-17; INTERLEUKINS; LIVER; LUNG; LYMPHOCYTES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MIDDLE AGED; PULMONARY FIBROSIS; SCHISTOSOMA MANSONI;

EID: 84891943376     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1315854111     Document Type: Article

References (43)

1. Ley B, et al. (2012) A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 156(10): 684-691.
2. WilsonMS, et al. (2010) Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J Exp Med 207(3): 535-552.
3. Wynn TA (2011) Integrating mechanisms of pulmonary fibrosis. J Exp Med 208(7): 1339-1350.
4. Noble PW, Barkauskas CE, Jiang D (2012) Pulmonary fibrosis: Patterns and perpetrators. J Clin Invest 122(8): 2756-2762.
5. Chiaramonte MG, et al. (1999) IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J Immunol 162(2): 920-930.
6. Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN (2000) Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL- 13 is a profibrotic agent. J Immunol 164(5): 2585-2591.
7. Wynn TA (2003) IL-13 effector functions. Annu Rev Immunol 21: 425-456.
8. Kraft M (2011) Asthma phenotypes and interleukin-13-moving closer to personalized medicine. N Engl J Med 365(12): 1141-1144.
9. Barron L, Wynn TA (2011) Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am J Physiol Gastrointest Liver Physiol 300(5):G723-G728.
10. Fallon PG, et al. (2006) Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med 203(4): 1105-1116.
11. Neill DR, et al. (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464(7293): 1367-1370.
12. Saenz SA, et al. (2010) IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 464(7293): 1362-1366.
13. Moro K, et al. (2010) Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463(7280): 540-544.
14. Price AE, et al. (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 107(25): 11489-11494.
15. Corrigan CJ, et al. (2011) Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy Clin Immunol 128(1): 116-124.
16. Mjösberg JM, et al. (2011) Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12(11): 1055-1062.
17. Angkasekwinai P, et al. (2007) Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 204(7): 1509-1517.
18. Fort MM, et al. (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15(6): 985-995.
19. Ballantyne SJ, et al. (2007) Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. J Allergy Clin Immunol 120(6): 1324-1331.
20. Pearce EJ, et al. (1996) Schistosoma mansoni in IL-4-deficient mice. Int Immunol 8(4): 435-444.
21. Min B, et al. (2004) Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med 200(4): 507-517.
22. Wakahara K, et al. (2013) Basophils are recruited to inflamed lungs and exacerbate memory Th2 responses in mice and humans. Allergy 68(2): 180-189.
23. Ohnmacht C, et al. (2010) Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity 33(3): 364-374.
24. Hams E, Fallon PG (2012) Innate type 2 cells and asthma. Curr Opin Pharmacol 12(4): 503-509.
25. Barlow JL, et al. (2013) IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 132(4): 933-941.
26. Wong SH, et al. (2012) Transcription factor RORα is critical for nuocyte development. Nat Immunol 13(3): 229-236.
27. Monticelli LA, et al. (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12(11): 1045-1054.
28. Sonnenberg GF, et al. (2012) Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336(6086): 1321-1325.
29. Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D (2011) CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34(1): 122-134.
30. Fallon PG, et al. (2002) IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 17(1): 7-17.
31. Kaviratne M, et al. (2004) IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol 173(6): 4020-4029.
32. Naik PK, et al.; COMET Investigators (2012) Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 303(12):L1046-L1056.
33. Selman M, King TE, Pardo A; American Thoracic Society; European Respiratory Society; American College of Chest Physicians (2001) Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134(2): 136-151.
34. Gauldie J, Bonniaud P, Sime P, Ask K, Kolb M (2007) TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans 35(Pt 4): 661-664.
35. Wynn TA (2008) Cellular and molecular mechanisms of fibrosis. J Pathol 214(2): 199-210.
36. Létuvé S, et al. (2006) IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol 117(3): 590-596.
37. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN (2000) T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med 191(6): 1069-1076.
38. Al-Shami A, et al. (2004) A role for thymic stromal lymphopoietin in CD4(+) T cell development. J Exp Med 200(2): 159-168.
39. McKenzie GJ, et al. (1998) Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9(3): 423-432.
40. Fallon PG, Emson CL, Smith P, McKenzie AN (2001) IL-13 overexpression predisposes to anaphylaxis following antigen sensitization. J Immunol 166(4): 2712-2716.
41. Bournazos S, et al. (2011) Copy number variation of FCGR3B is associated with susceptibility to idiopathic pulmonary fibrosis. Respiration 81(2): 142-149.
42. Mangan NE, Dasvarma A, McKenzie AN, Fallon PG (2007) T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation. Eur J Immunol 37(5): 1302-1312.
43. Amu S, et al. (2010) Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 125(5):1114-1124 e1118.